Bio-Pharma Studies

RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 ... MarketWatch RedHill Biopharma Ltd. (NASDAQ:RDHL) (tase:RDHL) (the "Company" or ... RedHill has completed several clinical studies with RHB-102 and is ...

Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock ... Wall Street Journal On April 4, 2014, Array BioPharma, Inc.'s (Array BioPharma) shares slipped by 5.01%, closing at $4.17 per share. Over the previous six month trading ...

Galena Biopharma vs. Peregrine Pharmaceuticals: Which is the Better Buy? Motley Fool Galena Biopharma vs. ... NeuVax is being studied in a phase 3 trial known as PRESENT in patients who exhibit low-to-moderate HER2 expression.

News Review: Celldex Therapeutics, Inc. (NASDAQ:CLDX), PDL BioPharma Inc. (NASDAQ:PDLI ... Market News Call The company on Apr. 7 reported results of preclinical studies evaluating the ... PDL BioPharma Inc. (NASDAQ:PDLI)'s shares climbed 0.61% to $8.24. ... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)'s stock gained 2.02% to $6.56.

Why Galena Biopharma, Inc. Shares Tumbled Motley Fool Why Galena Biopharma, Inc. Shares Tumbled ... cancer pain, and an operating loss of $12.4 million due to higher costs from ongoing clinical studies.

Pharma Report: Sunshine Biopharma (OTCQB: SBFM) Reports an Increase in Effectiveness of ... IT Business Net Sunshine Biopharma had previously announced that the concentration at which ... said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. ... by human microsomes stability studies and pharmacokinetics data in rats.

Kemwell augments lyophilization capability to boost contract devpt & manufacturing business pharmabiz.com Kemwell Biopharma, a global contract development and manufacturing ... small-scale manufacturing for pre-clinical studies and GMP manufacturing of ...